Quest revenues more than double in Q4

By LabPulse.com staff writers

February 5, 2021 -- Quest Diagnostics delivered record revenues for its fourth quarter and full year (end-December 30) due to high demand for COVID-19 testing.

For the fourth quarter, Quest posted revenue of $3 billion, up 56% compared with revenue of $1.9 billion in the same period the year before. The company's net income for the most recent period was $579 million, compared with a net income of $253 million in the fourth quarter of fiscal 2019.

For the full fiscal year, Quest posted net revenue of $9.44 billion, which is a 22% increase from 2019 when its net revenue was $7.7 billion. The company's net income for the full fiscal 2020 was $1.4 billion, compared with a net income of $838 million for the year before.

Quest wins CDC contract to sequence COVID-19 gene variants
Quest Diagnostics has received a contract from the U.S. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing for a project aimed...
6 trends to watch at AACC 2020
Although this year's meeting of the American Association for Clinical Chemistry (AACC) is virtual, it is probably more important than ever. Bruce Carlson...
FDA authorizes Quest's combined COVID-19 and flu RT-PCR test
The U.S. Food and Drug Administration (FDA) said it has authorized Quest Diagnostics' RC COVID-19 +Flu reverse transcription polymerase chain reaction...
Quest revenues jump nearly 43% in Q3
Quest Diagnostics announced a jump in its third-quarter revenues on continued demand for COVID-19 testing and the rapid recovery of healthcare utilization....
Anthem, Quest ink partnership
Anthem and Quest Diagnostics have announced a collaboration to improve healthcare delivery for both providers and patients.

Copyright © 2021 LabPulse.com

Last Updated ls 2/5/2021 4:15:46 PM